Items where Author is "Guazzelli, Alice"

[Atom feed] Atom [RSS2 feed] RSS
[BatchList tool] Batch List
Group by: Item Type | No Grouping
Jump to: Article
Number of items: 7.

Article

Guazzelli, Alice, Meysami, Parisa, Bakker, Emyr orcid iconORCID: 0000-0002-0091-1029, Demonacos, Constantinos, Giordano, Antonio, Krstic-Demonacos, Marija and Mutti, Luciano (2019) BAP1 Status Determines the Sensitivity of Malignant Mesothelioma Cells to Gemcitabine Treatment. International Journal of Molecular Sciences, 20 (2). ISSN 1661-6596

Guazzelli, Alice, Meysami, Parisa, Bakker, Emyr orcid iconORCID: 0000-0002-0091-1029, Bonanni, Ezio, Demonacos, Constantinos, Krstic-Demonacos, Marija and Mutti, Luciano (2019) What can independent research for mesothelioma achieve to treat this orphan disease? Expert Opinion on Investigational Drugs, 28 (8). pp. 719-732. ISSN 1354-3784

Tian, Kun, Bakker, Emyr orcid iconORCID: 0000-0002-0091-1029, Hussain, Michelle, Guazzelli, Alice, Alhebshi, Hasen, Meysami, Parisa, Demonacos, Constantinos, Schwartz, Jean-Marc, Mutti, Luciano et al (2018) p53 modeling as a route to mesothelioma patients stratification and novel therapeutic identification. Journal of Translational Medicine, 16 . p. 282.

Bakker, Emyr orcid iconORCID: 0000-0002-0091-1029, Guazzelli, Alice, Ashtiani, Firozeh, Demonacos, Constantinos, Krstic-Demonacos, Marija and Mutti, Luciano (2017) Immunotherapy advances for mesothelioma treatment. Expert Review of Anticancer Therapy, 17 (9). pp. 799-814. ISSN 1473-7140

Guazzelli, Alice, Bakker, Emyr orcid iconORCID: 0000-0002-0091-1029, Tian, Kun, Demonacos, Constantinos, Krstic-Demonacos, Marija and Mutti, Luciano (2017) Promising investigational drug candidates in phase I and phase II clinical trials for mesothelioma. Expert Opinion on Investigational Drugs, 26 (8). pp. 933-944. ISSN 1354-3784

Bakker, Emyr orcid iconORCID: 0000-0002-0091-1029, Guazzelli, Alice, Krstic-Demonacos, Marija, Sotgia, Federica, Lisanti, Michael and Mutti, Luciano (2017) Current and prospective pharmacotherapies for the treatment of pleural mesothelioma. Expert Opinion on Orphan Drugs, 5 (6). pp. 455-465.

Guazzelli, Alice, Bakker, Emyr orcid iconORCID: 0000-0002-0091-1029, Krstic-Demonacos, Marija, Lisanti, Michael P, Sotgia, Federica and Mutti, Luciano (2017) Anti-CTLA-4 therapy for malignant mesothelioma. Immunotherapy, 9 (3). pp. 273-280. ISSN 1750-743X

This list was generated on Thu Apr 25 12:05:01 2024 UTC.